These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
508 related articles for article (PubMed ID: 27911330)
1. FHL1B Interacts with Lamin A/C and Emerin at the Nuclear Lamina and is Misregulated in Emery-Dreifuss Muscular Dystrophy. Ziat E; Mamchaoui K; Beuvin M; Nelson I; Azibani F; Spuler S; Bonne G; Bertrand AT J Neuromuscul Dis; 2016 Nov; 3(4):497-510. PubMed ID: 27911330 [TBL] [Abstract][Full Text] [Related]
2. Expression and localization of nuclear proteins in autosomal-dominant Emery-Dreifuss muscular dystrophy with LMNA R377H mutation. Reichart B; Klafke R; Dreger C; Krüger E; Motsch I; Ewald A; Schäfer J; Reichmann H; Müller CR; Dabauvalle MC BMC Cell Biol; 2004 Mar; 5():12. PubMed ID: 15053843 [TBL] [Abstract][Full Text] [Related]
3. Emerin in health and disease. Koch AJ; Holaska JM Semin Cell Dev Biol; 2014 May; 29():95-106. PubMed ID: 24365856 [TBL] [Abstract][Full Text] [Related]
4. Abnormal proliferation and spontaneous differentiation of myoblasts from a symptomatic female carrier of X-linked Emery-Dreifuss muscular dystrophy. Meinke P; Schneiderat P; Srsen V; Korfali N; Lê Thành P; Cowan GJ; Cavanagh DR; Wehnert M; Schirmer EC; Walter MC Neuromuscul Disord; 2015 Feb; 25(2):127-36. PubMed ID: 25454731 [TBL] [Abstract][Full Text] [Related]
5. Nuclear envelope dystrophies show a transcriptional fingerprint suggesting disruption of Rb-MyoD pathways in muscle regeneration. Bakay M; Wang Z; Melcon G; Schiltz L; Xuan J; Zhao P; Sartorelli V; Seo J; Pegoraro E; Angelini C; Shneiderman B; Escolar D; Chen YW; Winokur ST; Pachman LM; Fan C; Mandler R; Nevo Y; Gordon E; Zhu Y; Dong Y; Wang Y; Hoffman EP Brain; 2006 Apr; 129(Pt 4):996-1013. PubMed ID: 16478798 [TBL] [Abstract][Full Text] [Related]
6. Dysregulation of FHL1 spliceforms due to an indel mutation produces an Emery-Dreifuss muscular dystrophy plus phenotype. Tiffin HR; Jenkins ZA; Gray MJ; Cameron-Christie SR; Eaton J; Aftimos S; Markie D; Robertson SP Neurogenetics; 2013 May; 14(2):113-21. PubMed ID: 23456229 [TBL] [Abstract][Full Text] [Related]
7. Increased solubility of lamins and redistribution of lamin C in X-linked Emery-Dreifuss muscular dystrophy fibroblasts. Markiewicz E; Venables R; Mauricio-Alvarez-Reyes ; Quinlan R; Dorobek M; Hausmanowa-Petrucewicz I; Hutchison C J Struct Biol; 2002; 140(1-3):241-53. PubMed ID: 12490172 [TBL] [Abstract][Full Text] [Related]
8. Mutations of the FHL1 gene cause Emery-Dreifuss muscular dystrophy. Gueneau L; Bertrand AT; Jais JP; Salih MA; Stojkovic T; Wehnert M; Hoeltzenbein M; Spuler S; Saitoh S; Verschueren A; Tranchant C; Beuvin M; Lacene E; Romero NB; Heath S; Zelenika D; Voit T; Eymard B; Ben Yaou R; Bonne G Am J Hum Genet; 2009 Sep; 85(3):338-53. PubMed ID: 19716112 [TBL] [Abstract][Full Text] [Related]
10. Lamin A/C Assembly Defects in Bertrand AT; Brull A; Azibani F; Benarroch L; Chikhaoui K; Stewart CL; Medalia O; Ben Yaou R; Bonne G Cells; 2020 Mar; 9(4):. PubMed ID: 32244403 [No Abstract] [Full Text] [Related]
11. Expression of emerin and lamins in muscle of patients with different forms of Emery-Dreifuss muscular dystrophy. Niebroj-Dobosz I; Fidzianska A; Hausmanowa-Petrusewicz I Acta Myol; 2003 Sep; 22(2):52-7. PubMed ID: 14959564 [TBL] [Abstract][Full Text] [Related]
12. The cell cycle dependent mislocalisation of emerin may contribute to the Emery-Dreifuss muscular dystrophy phenotype. Fairley EA; Riddell A; Ellis JA; Kendrick-Jones J J Cell Sci; 2002 Jan; 115(Pt 2):341-54. PubMed ID: 11839786 [TBL] [Abstract][Full Text] [Related]
13. LINC complex alterations in DMD and EDMD/CMT fibroblasts. Taranum S; Vaylann E; Meinke P; Abraham S; Yang L; Neumann S; Karakesisoglou I; Wehnert M; Noegel AA Eur J Cell Biol; 2012 Aug; 91(8):614-28. PubMed ID: 22555292 [TBL] [Abstract][Full Text] [Related]
14. A novel single nucleotide splice site mutation in FHL1 confirms an Emery-Dreifuss plus phenotype with pulmonary artery hypoplasia and facial dysmorphology. Pen AE; Nyegaard M; Fang M; Jiang H; Christensen R; Mølgaard H; Andersen H; Ulhøi BP; Østergaard JR; Væth S; Sommerlund M; de Brouwer AP; Zhang X; Jensen UB Eur J Med Genet; 2015 Apr; 58(4):222-9. PubMed ID: 25724586 [TBL] [Abstract][Full Text] [Related]
15. Left ventricular hypertrophy caused by a novel nonsense mutation in FHL1. Gossios TD; Lopes LR; Elliott PM Eur J Med Genet; 2013 May; 56(5):251-5. PubMed ID: 23500067 [TBL] [Abstract][Full Text] [Related]
16. Lamin A N-terminal phosphorylation is associated with myoblast activation: impairment in Emery-Dreifuss muscular dystrophy. Cenni V; Sabatelli P; Mattioli E; Marmiroli S; Capanni C; Ognibene A; Squarzoni S; Maraldi NM; Bonne G; Columbaro M; Merlini L; Lattanzi G J Med Genet; 2005 Mar; 42(3):214-20. PubMed ID: 15744034 [TBL] [Abstract][Full Text] [Related]
17. Nesprin-1 and -2 are involved in the pathogenesis of Emery Dreifuss muscular dystrophy and are critical for nuclear envelope integrity. Zhang Q; Bethmann C; Worth NF; Davies JD; Wasner C; Feuer A; Ragnauth CD; Yi Q; Mellad JA; Warren DT; Wheeler MA; Ellis JA; Skepper JN; Vorgerd M; Schlotter-Weigel B; Weissberg PL; Roberts RG; Wehnert M; Shanahan CM Hum Mol Genet; 2007 Dec; 16(23):2816-33. PubMed ID: 17761684 [TBL] [Abstract][Full Text] [Related]
18. Multitissular involvement in a family with LMNA and EMD mutations: Role of digenic mechanism? Ben Yaou R; Toutain A; Arimura T; Demay L; Massart C; Peccate C; Muchir A; Llense S; Deburgrave N; Leturcq F; Litim KE; Rahmoun-Chiali N; Richard P; Babuty D; Récan-Budiartha D; Bonne G Neurology; 2007 May; 68(22):1883-94. PubMed ID: 17536044 [TBL] [Abstract][Full Text] [Related]